Literature DB >> 10477563

Intracellular signaling of gp34, the OX40 ligand: induction of c-jun and c-fos mRNA expression through gp34 upon binding of its receptor, OX40.

Y Matsumura1, T Hori, S Kawamata, A Imura, T Uchiyama.   

Abstract

We investigated the intracellular signaling events of OX40 ligand (gp34), a member of the TNF family. To elucidate the intracellular signaling via gp34, we prepared a model system in which a human gp34-transfected mouse epithelial cell line was stimulated with a recombinant soluble form of OX40. We demonstrated that OX40 binding resulted in increase in c-jun and c-fos mRNA levels in this transfectant by Northern blot analysis, which was blocked by the pretreatment with anti-gp34 Ab. The studies with various gp34 deletion mutants showed that the cytoplasmic portion including the amino acid sequence 16-21 (RPRFER) was required for the induction of c-jun and c-fos mRNA expression. Furthermore, OX40 binding induced c-jun mRNA expression also in HUVECs, which in our previous study have been shown to express gp34 and interact with activated T cells through the OX40/gp34 pathway. On the other hand, c-fos mRNA was detectable neither in unstimulated HUVECs nor in gp34-stimulated HUVECs. These results indicate that the OX40/gp34 system generates two-way signals and may elicit biological effects on vascular endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10477563

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Essential role of OX40L on B cells in persistent alloantibody production following repeated alloimmunizations.

Authors:  Hiroshi Kato; Hidefumi Kojima; Naoto Ishii; Hidenori Hase; Yutaka Imai; Takashi Fujibayashi; Kazuo Sugamura; Testuji Kobata
Journal:  J Clin Immunol       Date:  2004-05       Impact factor: 8.317

2.  Highly active antiretroviral therapy in patients infected with human immunodeficiency virus increases CD40 ligand expression and IL-12 production in cells ex vivo.

Authors:  Alice M Nyakeriga; Jun Ying; Norah J Shire; Carl J Fichtenbaum; Claire A Chougnet
Journal:  Viral Immunol       Date:  2011-08       Impact factor: 2.257

3.  OX40 stimulation by gp34/OX40 ligand enhances productive human immunodeficiency virus type 1 infection.

Authors:  Y Takahashi; Y Tanaka; A Yamashita; Y Koyanagi; M Nakamura; N Yamamoto
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  OX40 signaling renders adult T-cell leukemia cells resistant to Fas-induced apoptosis.

Authors:  Akane Kunitomi; Toshiyuki Hori; Michiyuki Maeda; Takashi Uchiyama
Journal:  Int J Hematol       Date:  2002-10       Impact factor: 2.490

5.  Engagement of CD153 (CD30 ligand) by CD30+ T cells inhibits class switch DNA recombination and antibody production in human IgD+ IgM+ B cells.

Authors:  A Cerutti; A Schaffer; R G Goodwin; S Shah; H Zan; S Ely; P Casali
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

6.  TACI-BLyS signaling via B-cell-dendritic cell cooperation is required for naive CD8+ T-cell priming in vivo.

Authors:  Yaiza Diaz-de-Durana; George T Mantchev; Richard J Bram; Alessandra Franco
Journal:  Blood       Date:  2005-09-29       Impact factor: 22.113

Review 7.  Control of immunity by the TNFR-related molecule OX40 (CD134).

Authors:  Michael Croft
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

8.  Technical advance: soluble OX40 molecule mimics regulatory T cell modulatory activity on FcεRI-dependent mast cell degranulation.

Authors:  Riccardo Sibilano; Giorgia Gri; Barbara Frossi; Claudio Tripodo; Ryo Suzuki; Juan Rivera; Andrew S MacDonald; Carlo E Pucillo
Journal:  J Leukoc Biol       Date:  2011-06-07       Impact factor: 4.962

9.  OX40L blockade protects against inflammation-driven fibrosis.

Authors:  Muriel Elhai; Jérôme Avouac; Anna Maria Hoffmann-Vold; Nadira Ruzehaji; Olivia Amiar; Barbara Ruiz; Hassina Brahiti; Matthieu Ponsoye; Maxime Fréchet; Anne Burgevin; Sonia Pezet; Jérémy Sadoine; Thomas Guilbert; Carole Nicco; Hisaya Akiba; Vigo Heissmeyer; Arun Subramaniam; Robert Resnick; Øyvind Molberg; André Kahan; Gilles Chiocchia; Yannick Allanore
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-13       Impact factor: 11.205

10.  Lentiviral gp34/OX40L gene transfer into dendritic cells facilitates alloreactive CD4+ T-cell response in vitro.

Authors:  Masayuki Kobayashi; Akifumi Takaori-Kondo; Keiko Fukunaga; Hiroyuki Miyoshi; Takashi Uchiyama
Journal:  Int J Hematol       Date:  2004-05       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.